Aquestive Therapeutics, Inc. Ratios

Ratios Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 70.38%68.87%61.30%-224.10%70.51%59.34%58.82%-1,673.02%
EBT Margin -13.36%-91.02%-125.92%-1,394.58%-138.77%-114.11%-15.07%-4,380.06%
EBIT Margin -0.17%-72.57%-100.11%-1,072.33%-68.22%-88.23%-29.86%-3,052.68%
EBITDA Margin -17.07%-91.02%-125.92%-1,394.58%-138.77%-114.11%-15.56%-4,378.67%
Operating Margin -0.17%-72.57%-100.11%-1,072.33%-68.22%-88.23%-29.86%-3,052.68%
Net Margin -17.07%-91.02%-125.92%-1,394.58%-138.77%-114.11%-15.56%-4,378.67%
FCF Margin 5.61%-21.97%-115.71%-1,149.40%-66.67%-22.74%-14.58%-3,563.29%
Efficiency
Inventory Average 4.73M4.15M2.66M3.25M4.91M6.27M6.41M
Assets Average 64.98M82.67M70.68M62.44M59.53M57.24M79.42M
Equity Average -29.26M1.98M-27.31M-65.32M-100.34M-112.52M-83.32M
Invested Capital -68.60M14.68M-6.12M-45.92M-80.11M-67.05M-61.49M-15.16M
Asset Utilization Ratio 1.040.640.060.810.800.880.01
Leverage & Solvency
Interest Coverage Ratio -0.01-6.35-5.65-3.88-3.45-6.42-2.38-2.77
Debt to Equity -0.664.68-9.86-0.76-0.65-0.44-0.26-0.54
Debt Ratio 1.060.540.770.590.860.910.480.32
Equity Ratio -1.590.12-0.08-0.77-1.32-2.08-1.85-0.59
Times Interest Earned -0.01-6.35-5.65-3.88-3.45-6.42-2.38-2.77
Valuation
Enterprise Value -17.38M96.54M96.42M148.06M128.21M21.58M111.00M253.05M
Market Capitalization 157.14M145.75M179.87M156.24M48.85M134.87M324.59M
Return Ratios
Return on Sales -0.13%-0.91%-1.26%-13.95%-1.39%-1.14%-0.16%-43.79%
Return on Capital Employed -1.53%-0.82%-0.87%-0.86%-2.10%-0.39%-0.51%
Return on Invested Capital 0.80%
Return on Assets -0.94%-0.80%-0.79%-1.13%-0.91%-0.14%-0.56%
Return on Equity 2.10%-33.47%2.04%1.08%0.54%0.07%0.53%